AN2 Therapeutics, Inc. Banner Image

AN2 Therapeutics, Inc.

  • Ticker ANTX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
AN2 Therapeutics, Inc. Logo Image
  • 11-50 Employees
  • Based in Menlo Park, California
AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. Their initial candidate is epetraborole, which they are studying as a once-daily, oral treatment with a novel mechanism of action for patients with nontuberculous mycobacteria (NTM) lung disease, a rare, chronic, and progressiveMore infectious disease caused by bacteria known as mycobacteria that leads to irreversible lung damage and can be fatal.
AN2 Therapeutics, Inc.

Most Recent Annual Report

AN2 Therapeutics, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

AN2 Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!